The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants
Leigh F. Johnson,
Landon Myer,
Lise Jamieson
et al.
Abstract:Background:
Pregnant and breastfeeding women (PBW) in sub-Saharan Africa have high HIV incidence rates and associated risk of vertical transmission to their infants. Oral pre-exposure prophylaxis (PrEP) and injectable PrEP (long-acting cabotegravir, or CAB-LA) can potentially reduce this HIV transmission, but population-level impacts are uncertain.
Methods:
We extended a previously-developed model of HIV and PrEP in South Africa to allow for variable Pr… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.